43
Participants
Start Date
November 30, 2016
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
Artificial Pancreas
Subjects will be provided the Artificial Pancreas (AP) system which includes the inControl Diabetes Management Platform, a study insulin pump and continuous glucose monitor. This AP system is designed to help control blood sugar in people living with type 1 diabetes.
Mt. Sinai, New York
University of Virginia Center for Diabetes Technology, Charlottesville
Mayo Clinic, Rochester
Barbara Davis Center, University of Colorado, Aurora
William Sansum Diabetes Center, Santa Barbara
Stanford University, Stanford
Harvard University (Joslin Diabetes Center), Boston
University of Montpellier, Montpellier
University of Padova, Padua
Academic Medical Center, Amsterdam
Collaborators (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Jaeb Center for Health Research
OTHER
TypeZero Technologies, LLC
INDUSTRY
Tandem Diabetes Care, Inc.
INDUSTRY
DexCom, Inc.
INDUSTRY
Roche Diagnostic Ltd.
INDUSTRY
University of Virginia
OTHER